Robotic surgery for hepatic neoplasms: Where does it fit in the minimally invasive surgery landscape?

[摘要] Robotic surgery is commonly performed for cancers of the prostate and uterus but is still evolving for other tumors, such as colon and rectal malignancies. In 2017, more than 693,000 robotic-assisted procedures were performed in the U.S., and the overall market for surgical robotic systems was valued at more than $2.4 billion. An even more specialized tumor site being treated with robotic surgery is neoplastic disease of the liver (see Figure 1).

[学科分类] 外科医学